TRIBUTE - A phase III trial of erlotinib HCI (OSI-774) combined with carboplatin and paclitaxel (CP) chemotherapy in advanced non-small cell lung cancer (NSCLC) Meeting Abstract
| Authors: | Herbst, R. S.; Prager, D.; Hermann, R.; Miller, V.; Fehrenbacher, L.; Hoffman, P.; Johnson, B.; Sandler, A. B.; Mass, R.; Johnson, D. H. |
| Abstract Title: | TRIBUTE - A phase III trial of erlotinib HCI (OSI-774) combined with carboplatin and paclitaxel (CP) chemotherapy in advanced non-small cell lung cancer (NSCLC) |
| Meeting Title: | 40th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 22 |
| Issue: | 14 Suppl. |
| Meeting Dates: | 2004 Jun 5-8 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2004-07-15 |
| Start Page: | 619S |
| Language: | English |
| ACCESSION: | WOS:000223512402456 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2004.22.90140.7011 |
| Notes: | Meeting Abstract: 7011 -- 40th Annual Meeting of the American-Society-of-Clinical-Oncology -- JUN 05-08, 2004 -- New Orleans, LA -- S -- Source: Wos |
